Skip to content

IMAB

NovaBridge Biosciences

NASDAQ · Healthcare · Biotechnology · US

$2.88
−0.69%
Ask drillr

Latest reported

Last report date
Nov 13, 2025
EPS actual
-$0.25
EPS estimate
-$0.06
Revenue actual
Revenue estimate

Track record

Trailing twelve quarters

EPS beats (12Q)
4
EPS misses (12Q)
3
EPS in line (12Q)
0
Avg surprise (4Q)
-77.4%
Revenue beats (12Q)
1
Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Nov 13, 2025-$0.06-$0.25Miss -316.67%
Aug 20, 2025-$0.10-$0.07Beat 30.00%
May 15, 2025-$0.06-$0.04Beat 33.33%
Nov 14, 2024-$0.16-$0.25Miss -56.25%
Aug 28, 2024-$0.51-$0.07Beat 86.27%
Mar 29, 2024-$0.10$0.02Beat 116.17%$164.2K
Sep 29, 2023-$0.25$546.8K
May 1, 2023-$0.56$20.0M
Nov 10, 2022-$0.41$3.9M
Aug 30, 2022-$0.16-$0.54Miss -235.01%$19.1M
Nov 12, 2021-$0.54$5.4M
Apr 28, 2021$0.98$236.3M

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Mar 31, 2027